Predictors of Lipid Profile Abnormalities Among Patients with Metabolic Syndrome in Southwest Ethiopia: A Cross-Sectional Study

Abstract

Background: Lipid profile abnormalities are an integral part of metabolic syndrome (MetS) and major underlying causes of cardiovascular disease (CVD) and type-2 diabetes mellitus (T2DM). Lipid profile abnormalities in a patient with MetS are resulted due to the presence of central obesity and insulin resistance. In Ethiopia, the burden and predictors of lipid profile abnormalities in a patient with MetS are not well known. Thus, this study aimed to determine the prevalence of lipid profile abnormalities and predictors among patients with MetS in southwest Ethiopia. Methods and Materials: A cross-sectional study was conducted among 381 patients with MetS from September to December 2019 with a response rate of 100%. A structured questionnaire was used to collect data on socio-demographic and behavioral factors. Waist circumference, height, weight, and blood pressures were measured. The venous blood sample was collected for glucose and lipid profile determination. Data were entered and analyzed by using SPSS version 21. Binary logistic regression and Pearson's correlation analyses were performed. A p-value was set at a <0.05 for statistical significance. Results: In this study, about 58% of participants were at least one or more lipid profile abnormalities with the 95% CI (52.8-62.7). About 67.2%, 44.6%,18.4%, and 14.2% of study participants were low HDL, high TG, LDL, and TC, respectively. Central obesity (adjusted odds ratio (AOR): 1.89, 95% CI: 1.14-3.14), increasing age (AOR: 2.08, 95% CI: 1.27-3.4), higher BMI (AOR: 2.06, 95% CI: 1.23-3.4), being hypertensive (AOR: 3.48, 95% CI: 2.12-5.7) and increasing blood glucose level (AOR: 2.34, 95% CI: 1.36-4.03) were independent predictors of lipid profile abnormalities (dyslipidemia). Conclusion:In this study area, a high (58%) prevalence of dyslipidemia was observed in study participants, and increasing age, higher BMI, central obesity, hypertension, and high blood glucose level were identified as independent predictors of dyslipidemia among patients with MetS. Prevention and control of dyslipidemia and its predictors among patients with MetS were recommended.

Major depression, suicidal behaviors and neuroticism are pro-atherogenic states driven by lowered reverse cholesterol transport

“…The most important MetS biomarkers in our study were the increased PRO/ANTI_AI, Castelli risk index 1, and TG, as well as lower HDLc levels. These findings are consistent with previous reports that MetS is associated with increased TC, TG, Castelli risk index 1, and decreased HDLc (Haile et al, 2021; Kawamoto et al, 2011; Paredes et al, 2019). Other studies have found that MetS is associated with increased ApoB and decreased RCT (Lim et al, 2015; Sviridov et al, 2008).…”

Patterns of Dyslipidemia Among Acute Coronary Syndrome (ACS) Patients at a Tertiary Care Hospital in Lahore, Pakistan

“…It was seen that the second most common lipid abnormality was a higher level of TC. A study conducted in Southwest Ethiopia reported that the most prevalent lipid abnormality was low HDL with 67.2% and high TC with 44.6% prevalence as the second most prevalent parameter [ 20 ]. Another study reported that a high level of TC was the third most common abnormality [ 21 ].…”

Influence of Therapy Compliance Using Medication Possession Ratio Method for Patients with Metabolic Syndrome

“…24 Hypertension and high blood glucose levels also play a vital role as independent predictors of dyslipidemia in patients with metabolic syndrome. 25 These findings strengthen the recommendation for a comprehensive blood examination of patients with one of the disorders of metabolic syndrome.…”